Canada markets closed

Akari Therapeutics, Plc (AKTX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.7140-0.0160 (-0.92%)
At close: 04:00PM EDT
1.8000 +0.09 (+5.02%)
After hours: 04:36PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-9,890
-17,748
-17,424
-17,082
-16,846
Depreciation & amortization
3.61
4
4.126
8.907
19.205
Stock based compensation
1,055
735
314.65
325.523
1,047
Change in working capital
2,757
822
-1,984
-55.629
3,091
Other working capital
-17,455
-21,504
-18,847
-16,950
-12,918
Other non-cash items
-
-
-
900
-
Net cash provided by operating activites
-17,455
-21,504
-18,847
-16,950
-12,918
Cash flows from investing activities
Sales/Maturities of investments
-
-
-
-
0
Net cash used for investing activites
-
-
-
-
0
Cash flows from financing activities
Common stock issued
16,329
25,194
14,293
25,046
12,648
Net cash used privided by (used for) financing activities
16,424
25,288
14,293
25,074
12,648
Net change in cash
-970.489
3,889
-4,695
8,324
-236.276
Cash at beginning of period
8,151
9,361
14,056
5,732
5,968
Cash at end of period
7,121
13,250
9,361
14,056
5,732
Free Cash Flow
Operating Cash Flow
-17,455
-21,504
-18,847
-16,950
-12,918
Free Cash Flow
-17,455
-21,504
-18,847
-16,950
-12,918